Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Claxton

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Blood|February 15, 1997
Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemiaA Choudhury, J L Gajewski, J C Liang, et al.
Blood Cancer Journal|August 1, 2015
PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantationY Kong, J Zhang, D F Claxton, et al.
Blood|April 1, 1994
Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemiaD F Claxton, P Liu, H B Hsu, et al.
Blood|August 1, 1993
Identification of yeast artificial chromosomes containing the inversion 16 p-arm breakpoint associated with acute myelomonocytic leukemiaP Liu, D F Claxton, P Marlton, et al.
Blood|August 1, 1992
Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemiaD F Claxton, C L Reading, L Nagarajan, et al.
Blood|June 1, 1993
Expression of unusual immunophenotype combinations in acute myelogenous leukemiaC L Reading, E H Estey, Y O Huh, et al.
Blood|February 1, 1995
Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesisP Marlton, D F Claxton, P Liu, et al.
Blood|January 28, 1999
Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responsesB A Choudhury, J C Liang, E K Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancerN T Ueno, G Rondón, N Q Mirza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patientsA R Mato, B T Hill, N Lamanna, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood|February 15, 1997
Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemiaA Choudhury, J L Gajewski, J C Liang, et al.
Blood Cancer Journal|August 1, 2015
PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantationY Kong, J Zhang, D F Claxton, et al.
Blood|April 1, 1994
Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemiaD F Claxton, P Liu, H B Hsu, et al.
Blood|August 1, 1993
Identification of yeast artificial chromosomes containing the inversion 16 p-arm breakpoint associated with acute myelomonocytic leukemiaP Liu, D F Claxton, P Marlton, et al.
Blood|August 1, 1992
Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemiaD F Claxton, C L Reading, L Nagarajan, et al.
Blood|June 1, 1993
Expression of unusual immunophenotype combinations in acute myelogenous leukemiaC L Reading, E H Estey, Y O Huh, et al.
Blood|February 1, 1995
Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesisP Marlton, D F Claxton, P Liu, et al.
Blood|January 28, 1999
Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responsesB A Choudhury, J C Liang, E K Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancerN T Ueno, G Rondón, N Q Mirza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patientsA R Mato, B T Hill, N Lamanna, et al.
Pageof 2